| Pharmaceutical active ingredients: |
| Sodium Polystyrene Sulfonate |
| Available forms, composition and doses of PMS-Sodium Polysterene Sulfonate: |
| Powder; Oral, Rectal; Sodium Polystyrene Sulfonate 94.3 mg / gSuspension; Oral; Sodium Polystyrene Sulfonate 250 mg / ml |
| PMS-Sodium Polysterene Sulfonate medical category: |
| Human:Potassium-removing agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AE01 - Polystyrene Sulfonate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pharmascience |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
K-Exit | Sodium Polystyrene Sulfonate | Omega Laboratories |
| K-Exit Poudre | Sodium Polystyrene Sulfonate | Omega Laboratories |
| Kionex | Sodium Polystyrene Sulfonate | Paddock Laboratories |
| Oligo Z | Sodium Polystyrene Sulfonate | Unidentified Pharmaceutical Company |
| PHL-Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Pharmel |
| PMS-Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Pharmascience; IDS Group |
| Resinsodio | Sodium Polystyrene Sulfonate | Rubio Laboratorios; JDH Borneo Thailand; TTN Thitiratsanon; Zyfas Medical |
| Resonium | Sodium Polystyrene Sulfonate | Sanofi-Aventis; Irex Laboratoires |
| Resonium A | Sodium Polystyrene Sulfonate | Sanofi-Aventis; IDS Group; Irex Laboratoires |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Carolina Medical Products |